Longpre Lara 4
4 · Mirum Pharmaceuticals, Inc. · Filed May 12, 2021
Insider Transaction Report
Form 4
Longpre Lara
Chief Development Officer
Transactions
- Award
Common Stock
2021-05-10$14.62/sh+1,259$18,407→ 77,081 total
Footnotes (1)
- [F1]This Form 4 is being filed voluntarily to report the acquisition of 1,259 shares by the Reporting Person on May 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan.